A Reference in
Bioequivalence and
Phase I Clinical Trials
Synvia
1,600+ studies already conducted
Synvia was founded in 2005 as CAEP – Advanced Center for Studies and Research. Today, we conduct over 200 pharmaceutical bioequivalence studies annually and have built deep expertise in developing and validating bioanalytical methods.
With a track record of high-impact projects, we are committed to delivering top‐quality services and offering strategic support to our sponsors.
Our Bioequivalence Studies
Harmonized LATAM Studies
We conduct harmonized bioequivalence studies under international guidelines, ensuring our results are consistent and accepted by regulatory agencies across Latin America.
Submission Studies for Europe (EMA)
We have extensive experience conducting studies for submission to the European Medicines Agency (EMA), ensuring full regulatory compliance and adherence to the highest standards.
15,000 m² of State-of-the-Art Specialized Infrastructure
Fully equipped facilities that meet end-to-end projects, ensuring maximum efficiency and agility.
Clinical Facilities
Dedicated unit for recruitment of participants (screening), with the capacity for more than 5,000 screenings per month.
Intensive observation rooms equipped with outpatient cardiac monitoring and access to emergency care.
Specialized medical team with 24-hour assistance throughout the study period.
Integrated system for data management and electronic data capture during trials.
Safe, temperature-controlled area for medication storage.
162 beds in 4 wards with varied layouts to simultaneously accommodate different types of studies.
Dozens of Ultrafreezers and Freezers for different temperatures equipped with alarm and monitoring systems to ensure the safe storage of biological samples.
Bioanalytical Laboratory
We have a highly qualified technical team, including master’s and Ph.D. experts in method development and validation.
500+ methods
Developed and validated bioanalytical methods.
100,000+ samples
Analytical capacity exceeding 100,000 samples per month.
The Largest Analytical Park
O maior Parque Analítico da América Latina. Nossas instalações modernas incluem equipamentos de ponta, como:
+30 LC-MS/MS
GC-FID
ICP-MS
LC-FL
+25 LC-DAD
GC-MD/MS
ICP-OES
UV-VIS
Dissolutores e aparatos I e II
The largest Analytical Park in Latin America. Our modern facilities include state-of-the-art equipment, such as:
30+ LC-MS/MS
GC-FID
ICP-MS
LC-FL
25+ LC-DAD
GC-MD/MS
ICP-OES
UV-VIS
Dissolution testers and Apparatus I and II
Multiple support areas dedicated to providing the best experience for our clients and maintaining excellence in all processes.
Multiple support areas dedicated to providing the best experience for our clients and maintaining excellence in all processes.
Project Feasibility
Detailed assessment, including technical discussions and expertise exchange.
Project Management
Real-time tracking to ensure transparency and compliance with deadlines.
Participant Recruitment
Optimized recruitment through multiple channels and artificial intelligence.
Communication and Marketing
Targeted strategies to effectively attract new participants.
COMEX
Efficient importation of supplies and standards.
Technical Documentation
Preparation of precise and detailed analyses and reports.
Quality Assurance
A robust system aligned with the highest regulatory standards, including internal audits and external inspections.
Our solutions
Bioequivalence Studies
Bioanalytical Services
Pharmaceutical Equivalence
Phase I Clinical Trials (PK/PD)
Analytical Biostatistics
Analytical Services
Our solutions
Bioequivalence Studies
Phase I Clinical Trials (PK/PD)
Bioanalytical Services
Biostatistics
Pharmaceutical Equivalence
Analytical Services
Request a Quote
Contact our team using the form below:
30,000+ People Have Already Participated in Our Studies
Join us and help make medical treatments accessible to millions of Brazilians.